Scleroderma historical perspective: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m Bot: Removing from Primary care |
||
| (7 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Scleroderma}} | {{Scleroderma}} | ||
{{CMG}} | |||
{{CMG}}; {{AE}} {{MKA}} | |||
==Overview== | ==Overview== | ||
The word scleroderma comes from greek words; skleros (hard) and derma ([[skin]]). Scleroderma was first described by Carlo Curzio in Naples, Italy in 1753. The association between abnormal [[vasoconstriction]] and diffuse scleroderma was made in 1865 by Raynaud. | |||
==Historical Perspective== | ==Historical Perspective== | ||
===Discovery=== | |||
*The word scleroderma comes from greek words; skleros (hard) and derma ([[skin]]).<ref name="pmid18329541">{{cite journal |vauthors=Boin F, Hummers LK |title=Scleroderma-like fibrosing disorders |journal=Rheum. Dis. Clin. North Am. |volume=34 |issue=1 |pages=199–220; ix |date=February 2008 |pmid=18329541 |pmc=2706095 |doi=10.1016/j.rdc.2007.11.001 |url=}}</ref> | |||
*Hippocrates, in his literature has also described scleroderma as a patient having hard [[skin]].<ref name="pmid28473954">{{cite journal |vauthors=Morgan ND, Hummers LK |title=Scleroderma Mimickers |journal=Curr Treatm Opt Rheumatol |volume=2 |issue=1 |pages=69–84 |date=March 2016 |pmid=28473954 |pmc=5412724 |doi=10.1007/s40674-016-0038-7 |url=}}</ref> | |||
*Scleroderma was first described by Carlo Curzio in Naples, Italy in 1753.<ref name="pmid14493141">{{cite journal |vauthors=RODNAN GP, BENEDEK TG |title=An historical account of the study of progressive systemic sclerosis (diffuse scleroderma) |journal=Ann. Intern. Med. |volume=57 |issue= |pages=305–19 |date=August 1962 |pmid=14493141 |doi= |url=}}</ref> | |||
*The term scleroderma was first used by Fantonetti in 1837. | |||
*The association between abnormal [[vasoconstriction]] and diffuse scleroderma was made in 1865 by Raynaud. | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category: | |||
[[Category: | {{WH}} | ||
{{WS}} | |||
[[Category:Up-To-Date]] | |||
[[Category:Medicine]] | |||
[[Category:Dermatology]] | |||
[[Category:Rheumatology]] | [[Category:Rheumatology]] | ||
Latest revision as of 00:05, 30 July 2020
|
Scleroderma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Scleroderma historical perspective On the Web |
|
American Roentgen Ray Society Images of Scleroderma historical perspective |
|
Risk calculators and risk factors for Scleroderma historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: M. Khurram Afzal, MD [2]
Overview
The word scleroderma comes from greek words; skleros (hard) and derma (skin). Scleroderma was first described by Carlo Curzio in Naples, Italy in 1753. The association between abnormal vasoconstriction and diffuse scleroderma was made in 1865 by Raynaud.
Historical Perspective
Discovery
- The word scleroderma comes from greek words; skleros (hard) and derma (skin).[1]
- Hippocrates, in his literature has also described scleroderma as a patient having hard skin.[2]
- Scleroderma was first described by Carlo Curzio in Naples, Italy in 1753.[3]
- The term scleroderma was first used by Fantonetti in 1837.
- The association between abnormal vasoconstriction and diffuse scleroderma was made in 1865 by Raynaud.
References
- ↑ Boin F, Hummers LK (February 2008). "Scleroderma-like fibrosing disorders". Rheum. Dis. Clin. North Am. 34 (1): 199–220, ix. doi:10.1016/j.rdc.2007.11.001. PMC 2706095. PMID 18329541.
- ↑ Morgan ND, Hummers LK (March 2016). "Scleroderma Mimickers". Curr Treatm Opt Rheumatol. 2 (1): 69–84. doi:10.1007/s40674-016-0038-7. PMC 5412724. PMID 28473954.
- ↑ RODNAN GP, BENEDEK TG (August 1962). "An historical account of the study of progressive systemic sclerosis (diffuse scleroderma)". Ann. Intern. Med. 57: 305–19. PMID 14493141.